memantine | CARLAT PUBLISHING

Research Update

Memantine for Trichotillomania and Excoriation Disorder

June 1, 2024

Sarah Azarchi, MD

Sarah Azarchi, MD. Dr. Azarchi has no financial relationships with companies related to this material.

New analysis questions whether STAR*D followed its own protocols.

Expert Q&A

Managing Behavioral and Psychological Disturbances in the Nursing Home

April 1, 2024

Maureen C. Nash, MD

Maureen C. Nash, MD.

Medical Director, Providence ElderPlace PACE Oregon. Co-editor, Neurocognitive Behavioral Disorders: An Interdisciplinary Approach to Patient-Centered Care (Springer; 2019). All comments are Dr. Nash’s personal views and not those of any organization.

Dr. Nash has no financial relationships with companies related to this material.

Dr. Maureen Nash shares how CMS regulations for using antipsychotics in nursing homes affects quality of care.

Clinical Update

Treating Irritability in Autism: Functional and Medication Approaches

April 1, 2023

Joshua Feder, MD

Joshua D. Feder, MD. Editor-in-Chief, The Carlat Child Psychiatry Report.

Dr. Feder has no financial relationships with companies related to this material.

Antipsychotics can be very effective for irritability in autism, but they are often unnecessary, and the side effects are truly problematic. Don’t be the prescriber who hears irritability in autism and immediate prescribes antipsychotics. There are usually multiple steps to try before using the FDA approved antipsychotic medications.